N-[4-[2-[[(1S,3S)-3-aminocyclopentyl]amino]quinazolin-6-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide
C25H23ClFN5O2S — CID 169039469
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[2-[[(1S,3S)-3-aminocyclopentyl]amino]quinazolin-6-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide
N-[4-[2-[[(1S,3S)-3-aminocyclopentyl]amino]quinazolin-6-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide (PubChem CID 169039469) has the molecular formula C25H23ClFN5O2S and a molecular weight of 512.01 g/mol. Its IUPAC name is N-[4-[2-[[(1S,3S)-3-aminocyclopentyl]amino]quinazolin-6-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide.
Molecular Properties
| Compound Name | N-[4-[2-[[(1S,3S)-3-aminocyclopentyl]amino]quinazolin-6-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide |
|---|---|
| PubChem CID | 169039469 |
| Molecular Formula | C25H23ClFN5O2S |
| Molecular Weight | 512.01 g/mol |
| Exact Mass | 511.12 |
| IUPAC Name | N-[4-[2-[[(1S,3S)-3-aminocyclopentyl]amino]quinazolin-6-yl]-2-fluorophenyl]-2-chlorobenzenesulfonamide |
| SMILES | N[C@H]1CC[C@H](Nc2ncc3cc(-c4ccc(NS(=O)(=O)c5ccccc5Cl)c(F)c4)ccc3n2)C1 |
| InChI | InChI=1S/C25H23ClFN5O2S/c26-20-3-1-2-4-24(20)35(33,34)32-23-10-6-16(12-21(23)27)15-5-9-22-17(11-15)14-29-25(31-22)30-19-8-7-18(28)13-19/h1-6,9-12,14,18-19,32H,7-8,13,28H2,(H,29,30,31)/t18-,19-/m0/s1 |
| InChIKey | OHETXZYVQHKYEZ-OALUTQOASA-N |
| XLogP | 5.18 |
| TPSA | 110.00 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.01 |
| LogP ≤ 5 | 5.18 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169039469 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.